Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

They are Gustave Roussy

back to job offer list
back to clinical trials

They are Gustave Roussy

Bandeau témoignages

They are caregivers, doctors, patients, researchers, administrative staff, healthcare providers, donors, contributors…
All of them are involved in the fight against cancer with Gustave Roussy.

Discover their testimonies:

Témoignage d'Hélène, infirmière à Gustave Roussy

back to job offer list
back to clinical trials

Témoignage d'Astride, infirmière en pédiatrie

back to job offer list
back to clinical trials

Témoignage de Virginie, patiente à Gustave Roussy

back to job offer list
back to clinical trials

Témoignage d’Ulrick Birba

back to job offer list
back to clinical trials

Nos experts témoignent

Ulrick Birba,
Technicien principal du laboratoire de thérapie cellulaireUlrick Birba

Gustave Roussy and LXRepair announce a partnership for personalized radiotherapy of cancer

back to job offer list
back to clinical trials

21 october 2021

Gustave Roussy and LXRepair announce a partnership for personalized radiotherapy of cancer

PLXRepair, a pioneer in personalized radiotherapy with functional assays measuring DNA repair to predict treatment response, with a clinical proof-of-concept of radiotoxicity prediction in breast and prostate cancer, and Gustave Roussy, Europe's leading cancer center, announced today the launch of a joint laboratory to improve the personalization of radiotherapy.

Good to know 12

back to job offer list
back to clinical trials

Newsletter Good to Know

Gustave Roussy lance le programme Compass contre le cancer du sein triple négatif

back to job offer list
back to clinical trials

Villejuif, le 14 octobre 2021

Octobre rose // Tout n’est pas rose

Octobre rose - Radiothérapie en 5 jours : Gustave Roussy transforme la prise en charge du cancer du sein

back to job offer list
back to clinical trials

Le nouveau parcours compact de radiothérapie à Gustave Roussy consiste à diminuer le nombre de séances de radiothérapie après une opération ainsi que les délais de prise en charge tout en conservant la même efficacité. Dorénavant, les femmes de plus de 60 ans avec un cancer du sein localisé pourront suivre leur traitement de radiothérapie en 5 jours au lieu de 3 à 5 semaines.

SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe

back to job offer list
back to clinical trials

Villejuif, 05 october 2021

SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe

Prospective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug testing, 3D tumor cell culture, and AI analytics established at SEngine Precision Medicine to identify the best personalized therapeutic matches for patients

Pages